Exeter, England 18th October 2022 - Diagnexia Announce their Appointment as a Supplier on The Countess of Chester Hospital National Framework Agreement for Teleradiology, Telepathology and Telemedicine Services.

What this means for NHS Hospitals

Any NHS hospital is now free to access Diagnexia services through the framework, saving procurement time and cost. Hospitals can now access Diagnexia’s remote services to manage routine, urgent or specialist workloads and reduce backlogs in care. 

Primary diagnostic reports are returned in 3-5 working days from receipt of case information and data. Secondary consult reports are returned 7-10 working days from receipt of case information and data.

What Diagnexia offers the NHS

Diagnexia is your on-demand virtual pathology department. It provides access to remote GMC-registered subspeciality pathologists for primary diagnostics and secondary consult services. Diagnexia gives you access to over 35 subspeciality UK pathologists to support remote diagnostics. Using the Diagnexia service can enhance quality, improve turnaround times and help with backlog management.

Donal O'Shea, Chief Executive Officer of Deciphex

“The NHS has a real need for additional high-quality subspecialty pathology capacity, which in turn positively impacts on diagnostic turnaround time and patient outcomes. Being listed on the Countess of Cheshire Framework Agreement will make it easier for UK public bodies to gain awareness of and procure our digital pathology-enabled Diagnexia clinical pathology services, offering considerable benefits in quality and turnaround time for NHS laboratories“ 

About Diagnexia

Diagnexia (Diagnexia UK Ltd.) is an on-demand virtual pathology department that connects laboratories to subspeciality pathologists for primary diagnostics and secondary consult services using digital pathology. The Diagnexia service helps laboratories to improve their diagnostic turnaround times and reduce their pathology backlogs. Diagnexia is regulated by the UK Care Quality Commission pertaining to the provision of primary pathology diagnostic services. Diagnexia is a wholly owned subsidiary of Deciphex Ltd., who are focused on networking and accelerating the world's pathologists, by developing and globally deploying digital pathology and AI software and services, for clinical and research pathology.